Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Camptothecin Sensitizes Hepatocellular Carcinoma Cells to Sorafenib- Induced Ferroptosis Via Suppression of Nrf2
Ahmed S. Elkateb, Shahira Nofal, Sahar A. Ali, et al.
Inflammation (2023) Vol. 46, Iss. 4, pp. 1493-1511
Open Access | Times Cited: 19

Showing 19 citing articles:

Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy
Qiuhong Li, Kexin Chen, Tianyi Zhang, et al.
European Journal of Pharmacology (2023) Vol. 955, pp. 175913-175913
Closed Access | Times Cited: 36
Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease
Yutong Sui, Xue Geng, Ziwei Wang, et al.
Metabolism (2024) Vol. 157, pp. 155953-155953
Closed Access | Times Cited: 16
Current Progress of Ferroptosis Study in Hepatocellular Carcinoma
Xinyue Zhu, Xudong Sha, Yan Zang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3621-3637
Open Access | Times Cited: 11
SLC7A11 in hepatocellular carcinoma: potential mechanisms, regulation, and clinical significance
Tian-Ze Li, Jianwei Yi, Hua‐Jun Wu, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 5, pp. 2326-2342
Open Access | Times Cited: 8
The Role of Nrf2 in the Regulation of Mitochondrial Function and Ferroptosis in Pancreatic Cancer
Dinara Baiskhanova, H. Schäfer
Antioxidants (2024) Vol. 13, Iss. 6, pp. 696-696
Open Access | Times Cited: 6
Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications
Zhili Wu, Yanru Zhu, Wen‐Chao Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 352-352
Open Access | Times Cited: 5
Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges
Lin Gan, Weimin Wang, Jinxiu Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Ferroptosis: a new promising target for hepatocellular carcinoma therapy
Qiaoping Xu, Lanqi Ren, Ning Ren, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 10, pp. 2615-2636
Closed Access | Times Cited: 12
MCM4 potentiates evasion of hepatocellular carcinoma from sorafenib-induced ferroptosis through Nrf2 signaling pathway
Xujin Liu, Fan Zhang, Yu‐Chen Fan, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113107-113107
Closed Access | Times Cited: 4
Loss of Ftsj3 Promotes R-Loop-Associated DNA Damage and Facilitates Chemosensitivity in Camptothecin Resistant Lung Cancer Cells
Hongchengcheng Chen, Guihui Yu, Haodong Lin, et al.
(2025)
Closed Access
Nanocarriers for the delivery of plant-extracted camptothecin derivatives and hepatocellular carcinoma treatment
Jie Chen, Yanfeng Liu, Zelin Wang, et al.
Natural Product Research (2025), pp. 1-12
Closed Access
Insights into Sorafenib resistance in hepatocellular carcinoma: Mechanisms and therapeutic aspects.
Eman H. Yousef, Amal M. El Gayar, Nada F. Abo El‐Magd
Critical Reviews in Oncology/Hematology (2025), pp. 104765-104765
Closed Access
Breaking the Barriers of Therapy Resistance: Harnessing Ferroptosis for Effective Hepatocellular Carcinoma Therapy
Xianmei Lv, Gaochen Lan, Lujian Zhu, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1265-1278
Open Access | Times Cited: 3
Pharmacokinetics–Pharmacodynamics Modeling for Evaluating Drug–Drug Interactions in Polypharmacy: Development and Challenges
Di Zhao, Ping Huang, Li Yu, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 7, pp. 919-944
Closed Access | Times Cited: 2
The application of alkaloids in ferroptosis: A review
Bocheng Fan, Qihao Guo, Shu Wang
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117232-117232
Closed Access | Times Cited: 2
Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study
Xiumei Jiang, Pan Wang, Ke Su, et al.
Annals of Hepatology (2024), pp. 101578-101578
Open Access | Times Cited: 2
Targeting programmed cell death via active ingredients from natural plants: a promising approach to cancer therapy
Qian Li, Yan Tong, Jianxiang Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Potential antitumour effect of all-trans retinoic acid on regorafenib-treated human colon cancer cell lines
Mariam Hamad, Radwa Ali Mehana, Mohammad M. Abd-Al haseeb, et al.
Współczesna Onkologia (2023) Vol. 27, Iss. 3, pp. 198-210
Open Access | Times Cited: 3
The Curative and Preventative Effects of Traditional Chinese Medicine on Ferroptosis of Hepatocellular Carcinoma
Wei Peng, Renyi Yang, Kexiong Li, et al.
Natural Product Communications (2023) Vol. 18, Iss. 12
Open Access | Times Cited: 1
Multidisciplinary examples of applications: Papers using the MAL-PD/BD/CI/BI theory/method
Ting-Chao Chou
Elsevier eBooks (2024), pp. 181-218
Closed Access
Page 1

Scroll to top